Allergan Continues To Find New Uses For Botox: Cleared For Chronic Migraine In The UK
This article was originally published in The Pink Sheet Daily
Executive Summary
30 injections around the head needed to control chronic migraines with Botox.
You may also be interested in...
Botox For Migraine: How Will The Market Size Up?
The U.S. approval of Allergan Inc.’s Botox (onabotulinumtoxinA) to treat chronic migraines will surely be a boon to the company, but anyone attempting to pin down the market impact of the approval will encounter enough variables to cause a splitting headache.
Botox For Migraine: How Will The Market Size Up?
The U.S. approval of Allergan Inc.’s Botox (onabotulinumtoxinA) to treat chronic migraines will surely be a boon to the company, but anyone attempting to pin down the market impact of the approval will encounter enough variables to cause a splitting headache.
Class REMS For Botulinum Toxin Products Warns Against Interchangeabilty
FDA announced a class-wide REMS for botulinum toxin products that focuses on the dangers on interchangeability of the drugs.